S1 BUSCOPAN^® 10 mg tablets. Each tablet contains hyoscine
butylbromide 10 mg. Ref. No. E 501 (Act 101/1965)

S1 BUSCOPAN^® 0,1 % syrup. Each 5 ml of syrup contains
5 mg of hyoscine butylbromide. Reg. No. Z/11.2/93

For full prescribing information refer to the Professional Information approved by the medicines regulatory authority.

Applicant: Opella Healthcare South Africa (Pty) Ltd,
Reg. no.: 2020/176440/07.
4th Floor, Building I, Hertford Office Park, 90 Bekker Road, Midrand, 1652.

Tel: (011) 256 3700

www.sanofi.co.za

Side Effects/Safety:
za.CHCdrugsafety@sanofi.com

Medical Queries:
za.chcenquiries@sanofi.com

Product Quality Complaints:
CHC-ZAQAComplaints@sanofi.com